Clinical Trials for Avance Clinical

Explore 14 clinical trials worldwide

Showing 1-14 of 14 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Avance Clinical

Clinical Trials (14)

NCT07165067
A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors
PHASE1Not yet recruiting
36 participants
Started: Sep 20, 2025 · Completed: Jan 30, 2028
1 condition2 sponsors2 locations
NCT06975605
Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.
PHASE1Active, not recruiting
18 participants
Started: May 20, 2025 · Completed: Aug 30, 2025
3 conditions2 sponsors1 location
NCT06965881
Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults
PHASE1Recruiting
36 participants
Started: May 8, 2025 · Completed: Sep 30, 2025
3 conditions2 sponsors2 locations
NCT06899230
Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007
PHASE1Recruiting
72 participants
Started: Apr 8, 2025 · Completed: Oct 31, 2025
2 conditions2 sponsors1 location
NCT06877611
A Phase 1 Study of S-4321
PHASE1Recruiting
96 participants
Started: Apr 3, 2025 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT06828393
A Phase 1 Study of S-1117
PHASE1Recruiting
96 participants
Started: Mar 31, 2025 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT06302426
Trial of INI-4001 in Patients With Advanced Solid Tumours
PHASE1Not yet recruiting
50 participants
Started: Mar 29, 2024 · Completed: Apr 30, 2026
1 condition2 sponsors2 locations
NCT06205628
Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension
PHASE1Recruiting
120 participants
Started: Mar 21, 2024 · Completed: Sep 30, 2026
2 conditions3 sponsors3 locations
NCT05858736
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors
PHASE1Active, not recruiting
18 participants
Started: Jul 11, 2023 · Completed: Jun 15, 2026
17 conditions3 sponsors5 locations
NCT05799651
Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults
PHASE1Active, not recruiting
36 participants
Started: Apr 28, 2023 · Completed: Dec 31, 2024
1 condition5 sponsors1 location
NCT05768919
Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
PHASE1/PHASE2Recruiting
30 participants
Started: Mar 3, 2023 · Completed: May 31, 2027
1 condition2 sponsors2 locations
NCT05691361
Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients
PHASE1/PHASE2Recruiting
53 participants
Started: Dec 14, 2022 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT05261802
AVANCE-Houston FRAMEWorks Program Evaluation
NAActive, not recruiting
1,682 participants
Started: Apr 1, 2021 · Completed: Aug 15, 2025
1 condition2 sponsors1 location
NCT05293145
AVANCE-Houston Building Futures Program Evaluation
NAActive, not recruiting
718 participants
Started: Apr 1, 2021 · Completed: Aug 15, 2025
1 condition2 sponsors1 location